Prolonged IFN-γ–producing NKT response induced with α-galactosylceramide–loaded DCs (original) (raw)

• Bendelac, A., Rivera, M.N., Park, S.-H. & Roark, J.H. Mouse CD1-specific NK1 T cells. Annu. Rev. Immunol. 15, 535–562 (1997).
  Article CAS PubMed Google Scholar
• MacDonald, H.R. CD1d-glycolipid Tetramers. A new tool to monitor natural killer T cells in health and disease. J. Exp. Med. 192, 15–20 (2000).
  Article Google Scholar
• Godfrey, D.I., Hammond, K.J., Poulton, L.D., Smyth, M.J. & Baxter, A.G. NKT cells: facts, functions and fallacies. Immunol. Today 21, 573–583 (2000).
  Article CAS PubMed Google Scholar
• Hong, S. et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nature Med. 7, 1052–1056 (2001).
  Article CAS PubMed Google Scholar
• Sharif, S. et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nature Med. 7, 1057–1062 (2001).
  Article CAS PubMed Google Scholar
• Wang, B., Geng, Y.B. & Wang, C.R. CD1-restricted NKT cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194, 313–320 (2001).
  Article PubMed PubMed Central Google Scholar
• Pal, E. et al. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells. J. Immunol. 166, 662–668 (2001).
  Article CAS PubMed Google Scholar
• Jahng, A.W. et al. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1789–1799 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Singh, A.K. et al. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1801–1811 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Kawano, T. et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc. Natl. Acad. Sci. USA 95, 5690–5693 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Cui, J. et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623–1626 (1997).
  Article CAS PubMed Google Scholar
• Toura, I. et al. Inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide. J. Immunol. 163, 2387–2391 (1999).
  CAS PubMed Google Scholar
• Shin, T. et al. Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Vα14 NKT cells. Int. J. Cancer 91, 523–528 (2001).
  Article CAS PubMed Google Scholar
• Nakagawa, R. et al. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice. J. Immunol. 166, 6578–6584 (2001).
  Article CAS PubMed Google Scholar
• Smyth, M.J. et al. Sequential production of interferon-γ by NK1. 1+ T cells and natural killer cells is essential for the antimetastatic effect of α- galactosylceramide. Blood 99, 1259–1266 (2002).
  Article CAS PubMed Google Scholar
• Smyth, M.J. et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191, 661–668 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Smyth, M.J., Taniguchi, M. & Street, S.E. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J. Immunol. 165, 2665–2670 (2000).
  Article CAS PubMed Google Scholar
• Takeda, K. et al. Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12. Int. Immunol. 12, 909–914 (2000).
  Article CAS PubMed Google Scholar
• Gonzalez-Aseguinolaza, G. et al. α-galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA 97, 8461–8466 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kakimi, K., Guidotti, L.G., Koezuka, Y. & Chisari, F.V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192, 921–930 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Ishikawa, H. et al. CD4+ Vα14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int. Immunol. 12, 1267–1274 (2000).
  Article CAS PubMed Google Scholar
• Grant, E.P. et al. Molecular recognition of lipid antigens by T cell receptors. J. Exp. Med. 189, 195–205 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Kawano, T. et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278, 1626–1629 (1997).
  Article CAS PubMed Google Scholar
• Burdin, N. et al. Selective ability of mouse CD1 to present glycolipids: α-galactosylceramide specifically stimulates Vα14+ NK T lymphocytes. J. Immunol. 161, 3271–3281 (1998).
  CAS PubMed Google Scholar
• Brossay, L. et al. CD1d-mediated recognition of an α-galactosylceramide by natural killer T Cells is highly conserved through mammalian evolution. J. Exp. Med. 188, 1521–1528 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Spada, F.M., Koezuka, Y. & Porcelli, S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188, 1529–1534 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Matsuda, J.L. & Kronenberg, M. Presentation of self and microbial lipids by CD1 molecules. Curr. Opin. Immunol. 13, 19–25 (2001).
  Article CAS PubMed Google Scholar
• Morita, M. et al. Structure-activity relationship of α-galactosylceramides against B16-bearing mice. J. Med. Chem. 38, 2176 (1995).
• Zeng, Z.-H. et al. Crystal structure of mouse CD1: an MHC- like fold with a large hydrophobic binding groove. Science 277, 339–345 (1997).
  Article CAS PubMed Google Scholar
• Benlagha, K., Weiss, A., Beavis, A., Teyton, L. & Bendelac, A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191, 1895–1904 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Matsuda, J.L. et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192, 741–754 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Tomura, M. et al. A novel function of Vα14+ CD4+ NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 163, 93–101 (1999).
  CAS PubMed Google Scholar
• Kitamura, H. et al. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189, 1121–1128 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, O.O. et al. CD1d on myeloid dendritic cells stimulates cytokine secretion from and cytolytic activity of Vα24JαQ T cells: a feedback mechanism for immune regulation. J. Immunol. 165, 3756–3762 (2000).
  Article CAS PubMed Google Scholar
• Trobonjaca, Z., Leithauser, F., Moller, P., Schirmbeck, R. & Reimann, J. Activating immunity in the liver. I. liver dendritic cells (but not hepatocytes) are potent activators of IFN-γ release by liver NKT cells. J. Immunol. 167, 1413–1422 (2001).
  Article CAS PubMed Google Scholar
• Kadowaki, N. et al. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J. Exp. Med. 193, 1221–1226 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Takahashi, T. et al. Analysis of human Vα24+ CD4+ NKT cells activated by α-glycosylceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 164, 4458–4464 (2000).
  Article CAS PubMed Google Scholar
• Nishimura, T. et al. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12, 987–994 (2000).
  Article CAS PubMed Google Scholar
• Inaba, K., Metlay, J.P., Crowley, M.T. & Steinman, R.M. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172, 631–640 (1990).
  Article CAS PubMed Google Scholar
• Eberl, G. & MacDonald, H.R. Rapid death and regeneration of NKT cells in anti-CD3e or IL-12-treated mice: a major role for bone marrow in NKT cell homoestasis. Immunity 9, 345–353 (1998).
  Article CAS PubMed Google Scholar
• Osman, Y. et al. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur. J. Immunol. 30, 1919–1928 (2000).
  Article CAS PubMed Google Scholar
• Hayakawa, Y. et al. Critical contribution of IFN-γ and NK cells, but not perforin- mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide. Eur. J. Immunol. 31, 1720–1727 (2001).
  Article CAS PubMed Google Scholar
• Muller, G. et al. Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches. J. Invest. Dermatol. 114, 142–149 (2000).
  Article CAS PubMed Google Scholar
• Inaba, K. et al. The formation of immunogenic MHC class II- peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191, 927–936 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Granucci, F. et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nature Immunol. 2, 882–888 (2001).
  Article CAS Google Scholar
• Dunne, J. et al. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J. Immunol. 167, 3129–3138 (2001).
  Article CAS PubMed Google Scholar
• Wilson, S.B. & Byrne, M.C. Gene expression in NKT cells: defining a functionally distinct CD1d- restricted T cell subset. Curr. Opin. Immunol. 13, 555–561 (2001).
  Article CAS PubMed Google Scholar
• Nakui, M. et al. Potentiation of antitumor effect of NKT cell ligand, α- galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells. Clin. Exp. Metastasis 18, 147–153 (2000).
  Article CAS PubMed Google Scholar
• Carnaud, C. et al. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163, 4647–4650 (1999).
  CAS PubMed Google Scholar
• Inaba, K. et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693–1702 (1992).
  Article CAS PubMed Google Scholar